Cmed Group Announces Commercial Launch of Cmed Technology Ltd
The commercial launch of Cmed Technology brings Timaeus, Cmed’s next-generation clinical data capture and management solution, to the forefront for use by biopharmaceutical organisations worldwide.
Horsham, UK - May 18th 2010 - Cmed Group Ltd, the award-winning company that combines expertise in clinical research services with innovative technology, today announced completion of the commercial launch of Cmed Technology Ltd. Cmed Technology provides Timaeus, a next-generation solution for capture and management of clinical data.
As part of the Cmed Group, Cmed Technology will continue to collaborate with Cmed Clinical Research Services to meet Cmed client needs and obtain first-hand knowledge of real-world data management challenges. However, Cmed Technology will now directly provide Timaeus to study sponsors, Functional Service Providers (FSPs) and Contract Research Organisations (CROs). It will also partner with systems integrators (SIs) and consultancies to use Timaeus to improve clinical system architectures and implement operations excellence programmes.
“The development of Timaeus has benefited tremendously from its closeness to an operational CRO,” said Dr David Connelly, Chief Executive Officer of the Cmed Group. “This incubation enabled the development of a fundamentally different, next-generation platform that has been proven on demanding and complex clinical trials that challenge—and often overwhelm—conventional systems. I doubt this would have been possible from a standalone software company focused on short-term sales.”
Timaeus brings together leading-edge distributed computing, virtualisation, web, appliance and mobile technologies used by many of the world’s largest information systems into a single architecture platform, resulting in significant advantages. It can be used to configure standard and adaptive clinical trials with equal agility. Timaeus enables investigators and monitors working from remote trial locations and emerging markets to manage data with high speed and reliability—using only a mobile telephone connection. This, combined with Timaeus’ role-based workflow functionality, empowers investigators, monitors and data managers to manage data end-to-end, without need of reconciliation, saving much time and effort.
Cmed Technology provides customers the option to use Timaeus through either software-as-a-service or enterprise models, based on their specific needs. Both options include a range of supporting professional services. Each combines the benefits of managed services and turnkey cloud computing to set up and manage trials quickly, reliably and efficiently.
For more information, visit www.cmedtechnology.com
About Cmed Group Ltd
For pharmaceutical, biotech and research organizations that need to accelerate the right medicines to market, Cmed Group is an innovative clinical trials company that specializes in providing state-of-the-art technology products and diverse services. Unlike separate eClinical technology and contract research organization (CRO) vendors, Cmed Group takes a flexible and efficient approach in providing the right solution that meets our customers’ changing needs and expectations. As a result, Cmed Group expedites clinical trials operations to provide immediate real-world results for clinical trial sponsors through its companies: Cmed Clinical Services, a full-service CRO, and Cmed Technology, an eClinical technology provider. For further information visit www.cmedgroup.com
###
